REDUCED BRAIN 5-HT AND ELEVATED NE TURNOVER AND METABOLITES IN BIPOLAR AFFECTIVE-DISORDER

被引:94
作者
YOUNG, LT
WARSH, JJ
KISH, SJ
SHANNAK, K
HORNYKEIWICZ, O
机构
[1] UNIV TORONTO,CLARK INST PSYCHIAT,DEPT PHARMACOL,TORONTO,ON,CANADA
[2] UNIV TORONTO,CLARK INST PSYCHIAT,INST MED SCI,TORONTO,ON,CANADA
[3] UNIV VIENNA,INST BIOCHEM PHARMACOL,VIENNA,AUSTRIA
关键词
SEROTONIN; NORADRENALINE; BIPOLAR AFFECTIVE DISORDER; MOOD DISORDERS; LITHIUM; SUICIDE;
D O I
10.1016/0006-3223(94)91201-7
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Levels of norepinephrine (NE), serotonin (5-HT), dopamine (DA), and their major metabolites were determined in postmortem brain obtained from nine subjects with antemortem histories meeting DSM-III-R criteria for bipolar affective disorder. Compared with controls, no statistically significant differences were found in mean levels of NE, 5-HT, or DA in any brain area of bipolar subjects. NE turnover as estimated by the ratio of the major NE metabolite, 3-methoxy-4-hydroxyphenylethyleneglycol (MHPG) to NE was Increased in frontal (+ 107%), temporal (+ 103%), and occipital (+ 64%) cortex and thalamus (+ 83%). Significant decreases were found in the major 5-HT metabolite 5-hydroxyindoleacetic acid (5-HIAA), in frontal (- 54%) and parietal cortex (- 64%), and in 5-HIAA/5-HT ratio in temporal cortex (- 55%), with a trend for decreases in both measures in caudate nucleus. In addition, levels of the major DA metabolite, homovanillic acid (HVA) were significantly decreased (- 46%) in parietal cortex and HVA/DA ratios were significantly reduced (- 66%) in occipital cortex obtained from bipolar compared to control subjects. Our data, taken together with previous findings regarding monoamines in postmortem brain of depressed and suicide subjects, suggest that decreased 5-HT metabolite levels and turnover may be common to all mood disorders. Increased cortical NE turnover, however, may be a more important component in the pathophysiology of bipolar disorder.
引用
收藏
页码:121 / 127
页数:7
相关论文
共 37 条
[1]  
ANNITTO W, 1979, MANIC ILLNESS, P105
[2]  
ASTONJONES G, 1991, PROG BRAIN RES, V88, P47
[3]  
AZMITIA EC, 1978, HDB PSYCHOPHARMACOLO, V9, P233
[4]   DETERMINATION OF MONOAMINE AND MONOAMINE METABOLITES IN HUMAN BRAIN - POST-MORTEM STUDIES IN A GROUP OF SUICIDES AND IN A CONTROL GROUP [J].
BESKOW, J ;
GOTTFRIES, CG ;
ROOS, BE ;
WINBLAD, B .
ACTA PSYCHIATRICA SCANDINAVICA, 1976, 53 (01) :7-20
[5]  
BOURNE HR, 1968, LANCET, V2, P805
[6]  
CHEETHAM SC, 1991, BIOL ASPECTS AFFECTI, P191
[7]  
COCHRAN E, 1976, BIOL PSYCHIAT, V11, P283
[8]   NEUROTRANSMITTER RECEPTORS AND MONOAMINE METABOLITES IN THE BRAINS OF PATIENTS WITH ALZHEIMER-TYPE DEMENTIA AND DEPRESSION, AND SUICIDES [J].
CROW, TJ ;
CROSS, AJ ;
COOPER, SJ ;
DEAKIN, JFW ;
FERRIER, IN ;
JOHNSON, JA ;
JOSEPH, MH ;
OWEN, F ;
POULTER, M ;
LOFTHOUSE, R ;
CORSELLIS, JAN ;
CHAMBERS, DR ;
BLESSED, G ;
PERRY, EK ;
PERRY, RH ;
TOMLINSON, BE .
NEUROPHARMACOLOGY, 1984, 23 :1561-1569
[9]  
DELGADO PL, 1991, BIOL ASPECTS AFFECTI, P145
[10]  
ELLIOTT JM, 1991, BIOL ASPECTS AFFECTI, P95